Matches in SemOpenAlex for { <https://semopenalex.org/work/W2936243753> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2936243753 endingPage "638" @default.
- W2936243753 startingPage "632" @default.
- W2936243753 abstract "Cytochrome P450 family 2 subfamily C member 19 (CYP2C19), in liver, plays important roles in terms of drug metabolism. It is known that CYP2C19 poor metabolizers (PMs) lack CYP2C19 metabolic capacity. Thus, unexpected drug-induced liver injury or decrease of drug efficacy would be caused in CYP2C19 substrate-treated CYP2C19 PMs. However, it is difficult to evaluate the safety and effectiveness of drugs and candidate compounds for CYP2C19 PMs because there is currently no model for this phenotype. Here, using human induced pluripotent stem cells (human iPS cells) and our highly efficient genome-editing and hepatocyte differentiation technologies, we generated CYP2C19-knockout human iPS cell-derived hepatocyte-like cells (CYP2C19-KO HLCs) as a novel CYP2C19 PM model for drug development and research. The gene expression levels of hepatocyte markers were similar between wild-type iPS cell-derived hepatocyte-like cells (WT HLCs) and CYP2C19-KO HLCs, suggesting that CYP2C19 deficiency did not affect the hepatic differentiation potency. We also examined CYP2C19 metabolic activity by measuring S-mephenytoin metabolites using ultra-performance liquid chromatography-tandem mass spectrometry. The CYP2C19 metabolic activity was almost eliminated by CYP2C19 knockout. Additionally, we evaluated whether clopidogrel (CYP2C19 substrate)-induced liver toxicity could be predicted using our model. Unexpectedly, there was no significant difference in cell viability between clopidogrel-treated WT HLCs and CYP2C19-KO HLCs. However, the cell viability in clopidogrel- and ketoconazole (CYP3A4 inhibitor)-treated CYP2C19-KO HLCs was significantly enhanced as compared with that in clopidogrel- and DMSO-treated CYP2C19-KO HLCs. This result suggests that CYP2C19-KO HLCs can predict clopidogrel-induced liver toxicity. We succeeded in generating CYP2C19 PM model cells using human iPS cells and genome-editing technologies for pharmaceutical research. SIGNIFICANCE STATEMENT: Although unexpected drug-induced liver injury or decrease of drug efficacy would be caused in CYP2C19 substrate-treated CYP2C19 poor metabolizers, it is difficult to evaluate the safety and effectiveness of drugs and candidate compounds for CYP2C19 poor metabolizers because there is currently no model for this phenotype. Using human iPS cells and our highly efficient genome editing and hepatocyte differentiation technologies, we generated CYP2C19-knockout human iPS cell-derived hepatocyte-like cells as a novel CYP2C19 poor metabolizer model for drug development and research." @default.
- W2936243753 created "2019-04-25" @default.
- W2936243753 creator A5007934756 @default.
- W2936243753 creator A5011409446 @default.
- W2936243753 creator A5032890158 @default.
- W2936243753 creator A5040541688 @default.
- W2936243753 creator A5046894062 @default.
- W2936243753 creator A5048055524 @default.
- W2936243753 creator A5062623227 @default.
- W2936243753 creator A5072747383 @default.
- W2936243753 date "2019-04-08" @default.
- W2936243753 modified "2023-10-16" @default.
- W2936243753 title "Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells" @default.
- W2936243753 cites W1979392961 @default.
- W2936243753 cites W1979566817 @default.
- W2936243753 cites W1990232455 @default.
- W2936243753 cites W2010427019 @default.
- W2936243753 cites W2045530950 @default.
- W2936243753 cites W2054274413 @default.
- W2936243753 cites W2059224128 @default.
- W2936243753 cites W2064815984 @default.
- W2936243753 cites W2078338783 @default.
- W2936243753 cites W2108825946 @default.
- W2936243753 cites W2156853890 @default.
- W2936243753 cites W2159858918 @default.
- W2936243753 cites W2164386459 @default.
- W2936243753 cites W2202145688 @default.
- W2936243753 cites W2344315362 @default.
- W2936243753 cites W2544147805 @default.
- W2936243753 cites W2590265223 @default.
- W2936243753 cites W2741120316 @default.
- W2936243753 cites W2768460691 @default.
- W2936243753 cites W2771950797 @default.
- W2936243753 cites W2793671517 @default.
- W2936243753 doi "https://doi.org/10.1124/dmd.119.086322" @default.
- W2936243753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30962288" @default.
- W2936243753 hasPublicationYear "2019" @default.
- W2936243753 type Work @default.
- W2936243753 sameAs 2936243753 @default.
- W2936243753 citedByCount "17" @default.
- W2936243753 countsByYear W29362437532020 @default.
- W2936243753 countsByYear W29362437532021 @default.
- W2936243753 countsByYear W29362437532022 @default.
- W2936243753 countsByYear W29362437532023 @default.
- W2936243753 crossrefType "journal-article" @default.
- W2936243753 hasAuthorship W2936243753A5007934756 @default.
- W2936243753 hasAuthorship W2936243753A5011409446 @default.
- W2936243753 hasAuthorship W2936243753A5032890158 @default.
- W2936243753 hasAuthorship W2936243753A5040541688 @default.
- W2936243753 hasAuthorship W2936243753A5046894062 @default.
- W2936243753 hasAuthorship W2936243753A5048055524 @default.
- W2936243753 hasAuthorship W2936243753A5062623227 @default.
- W2936243753 hasAuthorship W2936243753A5072747383 @default.
- W2936243753 hasBestOaLocation W29362437531 @default.
- W2936243753 hasConcept C109650736 @default.
- W2936243753 hasConcept C140840227 @default.
- W2936243753 hasConcept C185592680 @default.
- W2936243753 hasConcept C2780035454 @default.
- W2936243753 hasConcept C526171541 @default.
- W2936243753 hasConcept C55493867 @default.
- W2936243753 hasConcept C62231903 @default.
- W2936243753 hasConcept C86803240 @default.
- W2936243753 hasConcept C89311334 @default.
- W2936243753 hasConcept C98274493 @default.
- W2936243753 hasConceptScore W2936243753C109650736 @default.
- W2936243753 hasConceptScore W2936243753C140840227 @default.
- W2936243753 hasConceptScore W2936243753C185592680 @default.
- W2936243753 hasConceptScore W2936243753C2780035454 @default.
- W2936243753 hasConceptScore W2936243753C526171541 @default.
- W2936243753 hasConceptScore W2936243753C55493867 @default.
- W2936243753 hasConceptScore W2936243753C62231903 @default.
- W2936243753 hasConceptScore W2936243753C86803240 @default.
- W2936243753 hasConceptScore W2936243753C89311334 @default.
- W2936243753 hasConceptScore W2936243753C98274493 @default.
- W2936243753 hasIssue "6" @default.
- W2936243753 hasLocation W29362437531 @default.
- W2936243753 hasLocation W29362437532 @default.
- W2936243753 hasOpenAccess W2936243753 @default.
- W2936243753 hasPrimaryLocation W29362437531 @default.
- W2936243753 hasRelatedWork W135333318 @default.
- W2936243753 hasRelatedWork W1980407312 @default.
- W2936243753 hasRelatedWork W1998996088 @default.
- W2936243753 hasRelatedWork W2034084843 @default.
- W2936243753 hasRelatedWork W2044015363 @default.
- W2936243753 hasRelatedWork W2166464521 @default.
- W2936243753 hasRelatedWork W2359517566 @default.
- W2936243753 hasRelatedWork W2369029332 @default.
- W2936243753 hasRelatedWork W2580961670 @default.
- W2936243753 hasRelatedWork W2899588041 @default.
- W2936243753 hasVolume "47" @default.
- W2936243753 isParatext "false" @default.
- W2936243753 isRetracted "false" @default.
- W2936243753 magId "2936243753" @default.
- W2936243753 workType "article" @default.